2025 annual financial data
SAB Biotherapeutics 2025 Operating margin
SAB Biotherapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -48,953,363 USD and net income was 13,273,683 USD.
Operating cash flow was -44,775,111 USD.
Get free SAB Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -48,953,363 USD
- Net income
- 13,273,683 USD
- Operating cash flow
- -44,775,111 USD